Results 241 to 250 of about 35,928 (280)

The Use of Routine Laboratory 17‐Hydroxyprogesterone for Identification of Cases of 21‐Hydroxylase Deficiency Congenital Adrenal Hyperplasia

Clinical Endocrinology, Volume 104, Issue 2, Page 123-129, February 2026.
ABSTRACT Background Clinical outcome studies of 21‐hydroxylase deficiency congenital adrenal hyperplasia (21OHD CAH) may be subject to selection bias due to incomplete case ascertainment. This study aimed to develop a methodology for identifying existing CAH cases and explore its utility to study clinical outcomes. Methods 17‐hydroxyprogesterone assays
Joseph McElvaney, Salma R. Ali, Amy R. Frank, Sophie Longmuir, Jane McNeilly, Malika Alimussina, Ruth McGowan, Syed Faisal Ahmed   +7 more
wiley   +1 more source

Synergistic associations of metformin and GLP‐1 receptor agonist use with adiposity‐related cancer incidence in people living with type 2 diabetes

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 946-959, February 2026.
Abstract Background Metformin and glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) may reduce the risk of adiposity‐related cancers in patients with type 2 diabetes (T2D). The potential synergistic effects of these treatments on cancer incidence remain unclear, considering their distinct biological mechanisms and their associated effects on body ...
Alex E. Henney, Megan Heague, David R. Riley, Theresa J. Hydes, Matthew Anson, Uazman Alam, Daniel J. Cuthbertson   +6 more
wiley   +1 more source

Too Dry for Primary Adrenal Insufficiency (PAI): PAI Masked by Volume Depletion. [PDF]

Cureus
Bathla JS, Chitale A, Shahzad S, Elbathani M, Sarvadevabatla N.   +4 more
europepmc   +1 more source

Pembrolizumab-Induced Primary Adrenal Insufficiency: A Rare But Life-Threatening Endocrine irAE

Syeda Sarah Raza, Mehr A Orakzai, Abdullah A Orakzai   +2 more
openalex   +1 more source

Regulatory T cells in autoimmune primary adrenal insufficiency. [PDF]

Clin Exp Immunol
Sjøgren T, Bjune JI, Husebye ES, Oftedal BE, Wolff ASB.   +4 more
europepmc   +1 more source

Dual-release hydrocortisone treatment improves serum and peripheral blood mononuclear cell inflammatory and immune profiles in patients with autoimmune primary adrenal insufficiency. [PDF]

Front Immunol
Tomasello L, Coppola A, Pizzolanti G, Giordano C, Arnaldi G, Guarnotta V.   +5 more
europepmc   +1 more source